Cargando…
Therapeutic drug monitoring in inflammatory bowel disease
Tumor necrosis factor (TNF)-α inhibitors and thiopurines are among the most important classes of medications utilized in the clinical management of Crohn’s disease and ulcerative colitis. A significant proportion of patients loses response to these agents or develops adverse effects during the cours...
Autores principales: | Kopylov, Uri, Ben-Horin, Shomron, Seidman, Ernest |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188926/ https://www.ncbi.nlm.nih.gov/pubmed/25331715 |
Ejemplares similares
-
Advances in the development of new biologics in inflammatory bowel disease
por: Ungar, Bella, et al.
Publicado: (2016) -
Capsule Endoscopy in Inflammatory Bowel Disease: Panenteric Capsule Endoscopy and Application of Artificial Intelligence
por: Ukashi, Offir, et al.
Publicado: (2023) -
Outcome of inflammatory bowel disease patients with prior malignancy
por: Shani, Uria, et al.
Publicado: (2023) -
Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease—Are We There Yet?
por: Levartovsky, Asaf, et al.
Publicado: (2020) -
Predictors of mortality in inflammatory bowel disease patients treated for pneumonia
por: Ukashi, Offir, et al.
Publicado: (2020)